Page 5 - Resure Sealant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Resure sealant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Resure Sealant Today - Breaking & Trending Today

Ocular Therapeutix's (OCUL) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Ocular Therapeutix (NASDAQ:OCUL – Free Report) in a research note published on Tuesday, Benzinga reports. The brokerage currently has a $12.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Ocular Therapeutix’s Q3 2023 earnings at ($0.28) EPS, Q4 2023 earnings at […] ....

United States , Robertw Baird , Charles Schwab Investment Management Inc , Ocular Therapeutix Inc , Lincoln National Corp , Profund Advisors , Citigroup Inc , Ocular Therapeutix , Free Report , Moderate Buy , Get Free Report , Schwab Investment Management , Resure Sealant , Ocular Therapeutix Daily ,

Ocular Therapeutix (NASDAQ:OCUL) Given "Buy" Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Ocular Therapeutix (NASDAQ:OCUL – Free Report) in a report released on Tuesday, Benzinga reports. HC Wainwright currently has a $12.00 price target on the biopharmaceutical company’s stock. OCUL has been the subject of several other research reports. Robert W. Baird boosted their price objective on shares […] ....

United States , Robertw Baird , York Mellon Corp , Ocular Therapeutix Inc , Lincoln National Corp , Carson Advisory Inc , Ocular Therapeutix , Free Report , Moderate Buy , Get Free Report , National Corp , New York Mellon Corp , Montreal Can , Carson Advisory , Resure Sealant , Ocular Therapeutix Daily , Nasdaq Ocul , Reiterated Rating , Hc Wainwright ,

Comparing Innoviva (NASDAQ:INVA) & Ocular Therapeutix (NASDAQ:OCUL)

Ocular Therapeutix (NASDAQ:OCUL – Free Report) and Innoviva (NASDAQ:INVA – Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations. Risk & Volatility Ocular Therapeutix has a beta of 1.22, […] ....

United States , Glaxo Group , Regeneron Pharmaceuticals Inc , Innoviva Inc , Affamed Therapeutics , Ocular Therapeutix Inc , Theravance Inc , Ocular Therapeutix , Free Report , Given Ocular Therapeutix , Resure Sealant , Regeneron Pharmaceuticals , Affamed Therapeutics Limited , Mosaic Biosciences , Sarissa Capital Management , Glaxo Group Limited , Ocular Therapeutix Daily , Nasdaq Ocul , Stock Comparison , Stock Analysis ,

Weekly Research Analysts' Ratings Updates for Ocular Therapeutix (OCUL)

Several analysts have recently updated their ratings and price targets for Ocular Therapeutix (NASDAQ: OCUL): 6/22/2023 – Ocular Therapeutix was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating. 6/14/2023 – Ocular Therapeutix was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 6/13/2023 – Ocular Therapeutix […] ....

United States , Robertw Baird , Belpointe Asset Management , Ahrens Investment Partners , Steward Partners Investment Advisory , News Ratings For Ocular Therapeutix Inc Daily , Ocular Therapeutix Inc , Ocular Therapeutix , Therapeutix Stock Down , Free Report , Partners Investment Advisory , Asset Management , Investment Partners , Captrust Financial Advisors , Financial Advisors , Resure Sealant , Ocular Therapeutix Inc Daily , Nasdaq Ocul ,

Ocular Therapeutix (NASDAQ:OCUL) Cut to "Sell" at StockNews.com

StockNews.com downgraded shares of Ocular Therapeutix (NASDAQ:OCUL – Get Rating) from a hold rating to a sell rating in a research note issued to investors on Thursday morning. Other equities analysts have also recently issued research reports about the stock. JMP Securities boosted their price objective on shares of Ocular Therapeutix from $11.00 to $12.00 […] ....

United States , Robertw Baird , Deltec Asset Management , Geode Capital Management , Vanguard Group Inc , Ocular Therapeutix Inc , Ocular Therapeutix , Get Rating , Moderate Buy , Asset Management , Street Corp , Capital Management , Resure Sealant , Ocular Therapeutix Daily , Nasdaq Ocul , Stocknews Com ,